APPA | AP Pharma On Alert With Upcoming NDA Re-submission

APPA Stock, AP Pharma, APF530“Honey honey, how you thrill me, ah-hah, honey honey” has been the theme for investors who bought into A.P. Pharma Inc. (APPA) prior to January 1, 2012. Without the issuance of one “SOS” all year, APPA stock has steadily climbed from 0.23 making the JMP Securities  “outperform” rating and $3.00 price target issued in June look like a “Nina, Pretty ...

Continue Reading →
0